Farmacoterapia en el paciente con claudicación intermitente

Intermittent claudication is the most common symptom of peripheral arterial disease. Besides the limitation in the quality of life of the patient, it represents an independent risk factor and high cardiovascular mortality. The overall treatment strategy begins with an adequate control of vascular risk factors and lifestyle habits of the patient. We also associate drugs to reduce the occurrence of ischemic complications or other peripheral arterial sectors, essentially, antiplatelet agents, statins and antihypertensives. The specific treatment for claudication includes supervised exercise programs and drug treatment. We must first choose from the drugs with most updated evidence, cilostazol and naftidrofuryl, considering pentoxifylline only as the second alternative.